Valuation: Berkley Renewables Inc.

Market Cap 364K 324K 302K 275K 519K 35.03M 524K 3.66M 1.42M 17.91M 1.37M 1.34M 57.47M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.55M 4.25M 3.87M 7.31M 493M 7.37M 51.44M 19.93M 252M 19.24M 18.83M 808M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 19/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 16/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
-0.24%-0.43%+35.74%+8.24% 152B
+1.53%+2.87%+57.33%+60.16% 99.93B
+0.05%+0.73%+28.06%+14.33% 74.16B
-0.30%-0.90%-7.04%-5.17% 68.92B
+2.78%+5.59%+98.16%+68.30% 59.83B
+0.41%+2.15%+31.31%-6.77% 58.06B
+1.04%+1.28%+38.84%+4.38% 54.79B
-0.43%-1.05%+29.00%+22.98% 51.72B
+1.13%-1.51%+35.77%-13.82% 41.28B
Average +0.60%+0.14%+38.57%+16.96% 66.1B
Weighted average by Cap. +0.56%+0.33%+38.67%+18.95%

Financials

2016 2017
Net sales 1.03M 919K 858K 782K 1.47M 99.41M 1.49M 10.38M 4.02M 50.82M 3.88M 3.8M 163M 1.72M 1.53M 1.43M 1.3M 2.46M 166M 2.48M 17.31M 6.71M 84.76M 6.48M 6.34M 272M
Net income 173K 153K 143K 131K 246K 16.6M 248K 1.73M 672K 8.49M 648K 634K 27.24M -631K -560K -523K -477K -899K -60.61M -907K -6.33M -2.45M -30.99M -2.37M -2.32M -99.44M
Net Debt 2.92M 2.59M 2.42M 2.2M 4.16M 280M 4.2M 29.27M 11.34M 143M 10.95M 10.71M 460M 4.76M 4.23M 3.95M 3.6M 6.79M 458M 6.85M 47.78M 18.52M 234M 17.88M 17.49M 751M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-